LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Biomanufacturing Policy Summit Report 2024: Policy pathways for biomanufacturing in Europe

14/05/2024

REPORT

Brussels, 14 May 2024 - The Biomanufacturing Policy Summit is an annual meeting organised by EuropaBio that brings together biotech industry representatives and policymakers to discuss the most timely and relevant topics for biomanufacturing across sectors. The 2024 edition occurred in Brussels on 13th March and gathered 73 participants, including participants from the European Commission and the European Parliament.

“Policy pathways for biomanufacturing in Europe” was the Summit theme and the umbrella topic for discussions on the best ways to defragment and accelerate biomanufacturing in the EU, plus biomanufacturing policies from other global regions. It is a critical timing for biomanufacturing, as different policy files are underway at EU level, with an impact on relevant products or processes including biopharmaceuticals, new genomic techniques, detergents, alternative proteins and cell-cultivation .

This report summarizes the Summit’s main discussion points and takeaways and uses them as a foundation to build a Strengths, Weaknesses, Opportunities and Threats (SWOT) analysis for biomanufacturing in Europe. The analysis is further refined with data from recent reports and examples provided by EuropaBio's members, in order to add evidence and practical examples to support the arguments. Following the 2023 report which presented 10 recommendations for biomanufacturing, the 2024 SWOT analysis aims to act as an open conclusion from the Summit, adding substance to the ongoing debate around biomanufacturing in Europe.

The report stresses the urgent need to address the question “What does the EU want to be?” and build an answer with pillars in innovation, skills, smart and agile legislation and financial instruments, and the Single Market. The EU needs a smart industrial policy for biotech and biomanufacturing rooted in science-based policymaking, which promotes and incentivises the scale-up of infrastructures and sustainable solutions and creates innovative and resilient supply-chains, whilst answering the EU’s long-term ambitions.

Biomanufacturing Policy Summit Report 2024: Policy pathways for biomanufacturing in Europe


Download
Share
Francesca Degli Agostini
Francesca Degli Agostini

Related posts

22/05/2025

Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World


Read more
19/03/2025

Measuring the Economic Footprint of the Biotechnology Industry in the European Union


Read more
19/03/2025

Biotech as a critical economic asset for Europe: WifOR Institute study updated for EuropaBio


Read more

Important links

  • Adisseo joins EuropaBio: Feeding Animals Sustainably Around the World
  • Ensuring Biotech Integration in the Single Market

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.